XML 140 R122.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule I - Condensed Financial Information of Parent Company - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net loss for the period $ (109,860) $ (96,197) $ (27,571)
Excess tax benefits on share-based compensation expense 0 0 (193)
Stock-based compensation expense 7,021 8,134 7,599
Deferred income taxes (recovery) 854 (13,040) (6,981)
Amortization of discontinued cash flow hedge 0 (1,144) (761)
Loss (gain) on change in the fair value of forward contracts 0 1,624 281
Accounts receivable 1,328 (3,802) (3,825)
Prepaid expenses and deposits 331 (382) 3,981
Income taxes recoverable (480) 734 3,355
Accounts payable (3,391) (5,319) 6,754
Accrued liabilities 1,826 9,044 7,411
Customer deposits (2,675) 3,552 (1,191)
Net cash provided by (used in) operating activities (19,745) (4,771) 19,876
Proceeds received on exercise of stock options 43 0 1,096
Net cash (used in) provided by financing activities 44,498 178,836 132,007
Net cash used in investing activities (56,493) (92,583) (137,492)
Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents (31,740) 81,482 14,391
Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of year 104,978 23,496 9,105
Cash and cash equivalents, restricted cash, and restricted cash equivalents end of year 73,238 104,978 23,496
Parent Company [Member]      
Net loss for the period (109,860) (96,197) (27,571)
Excess tax benefits on share-based compensation expense 0 0 (193)
Stock-based compensation expense 5,288 6,035 5,779
Deferred income taxes (recovery) 755 (11,804) (6,689)
Amortization of discontinued cash flow hedge 0 (1,144) (761)
Loss (gain) on change in the fair value of forward contracts 0 1,624 281
Undistributed earnings of equity method investments 99,393 101,352 25,348
Accounts receivable 0 381 (482)
Prepaid expenses and deposits (99) (82) (49)
Income taxes recoverable (63) 1,208 532
Accounts payable (147) (492) 507
Accrued liabilities 1,151 195 195
Customer deposits 187 0 0
Net cash provided by (used in) operating activities (3,395) 1,076 (3,103)
Net proceeds received from (paid to) subsidiaries 3,978 2,078 1,101
Proceeds received on exercise of stock options 0 0 1,096
Net cash (used in) provided by financing activities 3,978 2,078 2,197
Investment in unrelated company 0 0 (2,012)
Net cash used in investing activities 0 0 (2,012)
Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents 583 3,154 (2,918)
Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of year 7,051 3,897 6,815
Cash and cash equivalents, restricted cash, and restricted cash equivalents end of year $ 7,634 $ 7,051 $ 3,897